|
OMIM |
Link |
Information gain |
01 |
|
BL
|
[NCBI]
|
0.00607225
|
|
|
waardenburg syndrome, type iic
|
[NCBI]
|
0.00111368
|
|
|
oslam syndrome
|
[NCBI]
|
0.000901736
|
|
|
vitamin d-dependent rickets, type ii, with normal vitamin d receptor
|
[NCBI]
|
0.000821799
|
|
|
XLP1
|
[NCBI]
|
0.000798128
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000769921
|
|
|
pygmy
|
[NCBI]
|
0.00058827
|
|
|
scott syndrome
|
[NCBI]
|
0.000542981
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000535602
|
|
|
hodgkin lymphoma
|
[NCBI]
|
0.000501441
|
|
|
EBVS1
|
[NCBI]
|
0.000498018
|
|
|
AIC
|
[NCBI]
|
0.000462005
|
|
|
CF
|
[NCBI]
|
0.000378275
|
|
|
WAS
|
[NCBI]
|
0.000311649
|
|
|
RA
|
[NCBI]
|
0.000294385
|
|
|
LAD
|
[NCBI]
|
0.000176635
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
0.000139533
|
|
|
IRF7
|
[NCBI]
|
0.000132282
|
|
|
SH2D1A
|
[NCBI]
|
0.000117603
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
0.000104014
|
|
|
CHS
|
[NCBI]
|
9.91222e-05
|
|
|
ITGB2
|
[NCBI]
|
9.29429e-05
|
|
|
IL10
|
[NCBI]
|
8.29199e-05
|
|
|
CR2
|
[NCBI]
|
7.55326e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
7.04204e-05
|
|
|
BCGF
|
[NCBI]
|
6.97059e-05
|
|
|
TNF
|
[NCBI]
|
6.66085e-05
|
|
|
BCL2
|
[NCBI]
|
6.63621e-05
|
|
|
MYC
|
[NCBI]
|
6.10388e-05
|
|
|
AT
|
[NCBI]
|
6.03586e-05
|
|
|
ALK
|
[NCBI]
|
5.56773e-05
|
|
|
FANCC
|
[NCBI]
|
5.30323e-05
|
|
|
lig4 syndrome
|
[NCBI]
|
4.95827e-05
|
|
|
MUC1
|
[NCBI]
|
4.81483e-05
|
|
|
CCR7
|
[NCBI]
|
4.78585e-05
|
|
|
TNFSF6
|
[NCBI]
|
4.77277e-05
|
|
|
LIP
|
[NCBI]
|
4.66766e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.54589e-05
|
|
|
JAK3
|
[NCBI]
|
4.40067e-05
|
|
|
RBPSUH
|
[NCBI]
|
4.3578e-05
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
4.25909e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
4.25909e-05
|
|
|
APC
|
[NCBI]
|
4.18906e-05
|
|
|
EBI3
|
[NCBI]
|
4.05527e-05
|
|
|
TPO
|
[NCBI]
|
3.9286e-05
|
|
|
FA
|
[NCBI]
|
3.65174e-05
|
|
|
EBI2
|
[NCBI]
|
3.64998e-05
|
|
|
renal ubiquitous protein 1
|
[NCBI]
|
3.64998e-05
|
|
|
killer-specific secretory protein, 37-kd
|
[NCBI]
|
3.64998e-05
|
|
|
IS
|
[NCBI]
|
3.59523e-05
|
|
|
TNFRSF6B
|
[NCBI]
|
3.39766e-05
|
|
|
INSR
|
[NCBI]
|
3.36559e-05
|
|
|
SCN3
|
[NCBI]
|
3.27719e-05
|
|
|
SCZD2
|
[NCBI]
|
3.27719e-05
|
|
|
BCL6
|
[NCBI]
|
3.1796e-05
|
|
|
SLAMF1
|
[NCBI]
|
3.1796e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.17867e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
3.1413e-05
|
|
|
UBN1
|
[NCBI]
|
2.9178e-05
|
|
|
UCKL1
|
[NCBI]
|
2.9178e-05
|
|
|
ZNF271
|
[NCBI]
|
2.9178e-05
|
|
|
HLA-DRB5
|
[NCBI]
|
2.9178e-05
|
|
|
DGCR6L
|
[NCBI]
|
2.9178e-05
|
|
|
RARS1
|
[NCBI]
|
2.9178e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
2.90352e-05
|
|
|
SCZD4
|
[NCBI]
|
2.79835e-05
|
|
|
UNG
|
[NCBI]
|
2.78884e-05
|
|
|
CGD
|
[NCBI]
|
2.74331e-05
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
2.70068e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
2.70068e-05
|
|
|
TANK
|
[NCBI]
|
2.64177e-05
|
|
|
DGCR6
|
[NCBI]
|
2.64177e-05
|
|
|
POLD2
|
[NCBI]
|
2.64177e-05
|
|
|
MMP9
|
[NCBI]
|
2.59863e-05
|
|
|
SYBL1
|
[NCBI]
|
2.4627e-05
|
|
|
CD48
|
[NCBI]
|
2.4627e-05
|
|
|
ORC2L
|
[NCBI]
|
2.4627e-05
|
|
|
WAPAL
|
[NCBI]
|
2.4627e-05
|
|
|
JMML
|
[NCBI]
|
2.44902e-05
|
|
|
ADA
|
[NCBI]
|
2.33498e-05
|
|
|
SLAMF6
|
[NCBI]
|
2.32968e-05
|
|
|
EGF
|
[NCBI]
|
2.30075e-05
|
|
|
CCL17
|
[NCBI]
|
2.29049e-05
|
|
|
KNSL4
|
[NCBI]
|
2.22379e-05
|
|
|
FER
|
[NCBI]
|
2.22379e-05
|
|
|
FGR
|
[NCBI]
|
2.22379e-05
|
|
|
RPL22
|
[NCBI]
|
2.22379e-05
|
|
|
TNFRSF10D
|
[NCBI]
|
2.22379e-05
|
|
|
BIK
|
[NCBI]
|
2.22379e-05
|
|
|
BTK
|
[NCBI]
|
2.21327e-05
|
|
|
MAP3K7IP2
|
[NCBI]
|
2.13581e-05
|
|
|
GNLY
|
[NCBI]
|
2.13581e-05
|
|
|
CVID
|
[NCBI]
|
2.10724e-05
|
|
|
TRAF3
|
[NCBI]
|
2.06058e-05
|
|
|
HNRPA1
|
[NCBI]
|
2.06058e-05
|
|
|
YES1
|
[NCBI]
|
2.06058e-05
|
|
|
PIGR
|
[NCBI]
|
2.02185e-05
|
|
|
MAPK10
|
[NCBI]
|
1.99487e-05
|
|
|
TYK2
|
[NCBI]
|
1.93655e-05
|
|
|
CD244
|
[NCBI]
|
1.93655e-05
|
|
|
TRAF1
|
[NCBI]
|
1.88413e-05
|
|
|
IKBKAP
|
[NCBI]
|
1.83655e-05
|
|
|
BCL2A1
|
[NCBI]
|
1.83655e-05
|
|
|
TOP2A
|
[NCBI]
|
1.83655e-05
|
|
|
CD55
|
[NCBI]
|
1.83655e-05
|
|
|
LTK
|
[NCBI]
|
1.83655e-05
|
|
|
STMN1
|
[NCBI]
|
1.79298e-05
|
|
|
LDLRAP1
|
[NCBI]
|
1.75281e-05
|
|
|
EGFR
|
[NCBI]
|
1.74456e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
1.74433e-05
|
|
|
STAT1
|
[NCBI]
|
1.74007e-05
|
|
|
MNDA
|
[NCBI]
|
1.71555e-05
|
|
|
TNFRSF10C
|
[NCBI]
|
1.68082e-05
|
|
|
AHCY
|
[NCBI]
|
1.64829e-05
|
|
|
NGFR
|
[NCBI]
|
1.63766e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.61841e-05
|
|
|
GNB3
|
[NCBI]
|
1.61771e-05
|
|
|
PWS
|
[NCBI]
|
1.60373e-05
|
|
|
NCF1
|
[NCBI]
|
1.58887e-05
|
|
|
IL7R
|
[NCBI]
|
1.58887e-05
|
|
|
IL6
|
[NCBI]
|
1.55101e-05
|
|
|
MCP
|
[NCBI]
|
1.54076e-05
|
|
|
CD
|
[NCBI]
|
1.51995e-05
|
|
|
NME1
|
[NCBI]
|
1.511e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.50514e-05
|
|
|
IL12A
|
[NCBI]
|
1.42292e-05
|
|
|
CD59
|
[NCBI]
|
1.40312e-05
|
|
|
IL2RG
|
[NCBI]
|
1.40312e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.38407e-05
|
|
|
TSG101
|
[NCBI]
|
1.38407e-05
|
|
|
CD8A
|
[NCBI]
|
1.36572e-05
|
|
|
MBP
|
[NCBI]
|
1.36429e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
1.34802e-05
|
|
|
THRA
|
[NCBI]
|
1.33092e-05
|
|
|
XPC
|
[NCBI]
|
1.33092e-05
|
|
|
CD40LG
|
[NCBI]
|
1.29841e-05
|
|
|
RECQL3
|
[NCBI]
|
1.28292e-05
|
|
|
CYBB
|
[NCBI]
|
1.2679e-05
|
|
|
HLA-B
|
[NCBI]
|
1.2679e-05
|
|
|
IL12B
|
[NCBI]
|
1.23917e-05
|
|
|
IL2
|
[NCBI]
|
1.23502e-05
|
|
|
CDK6
|
[NCBI]
|
1.22541e-05
|
|
|
ICAM1
|
[NCBI]
|
1.21203e-05
|
|
|
HSAN3
|
[NCBI]
|
1.19634e-05
|
|
|
PDCD8
|
[NCBI]
|
1.1846e-05
|
|
|
coproporphyria
|
[NCBI]
|
1.15014e-05
|
|
|
GHR
|
[NCBI]
|
1.14895e-05
|
|
|
NGFB
|
[NCBI]
|
1.09177e-05
|
|
|
RIPK1
|
[NCBI]
|
1.0555e-05
|
|
|
CTNS
|
[NCBI]
|
1.04867e-05
|
|
|
ABL1
|
[NCBI]
|
1.04606e-05
|
|
|
MSH2
|
[NCBI]
|
1.01881e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.01881e-05
|
|
|
NFKB1
|
[NCBI]
|
1.01006e-05
|
|
|
KLF4
|
[NCBI]
|
1.00148e-05
|
|
|
PGK1
|
[NCBI]
|
9.68637e-06
|
|
|
FOXP3
|
[NCBI]
|
8.82155e-06
|
|
|
THRB
|
[NCBI]
|
8.69211e-06
|
|
|
TSHR
|
[NCBI]
|
8.38392e-06
|
|
|
HLA-A
|
[NCBI]
|
7.77295e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
7.57036e-06
|
|
|
CCL22
|
[NCBI]
|
7.47251e-06
|
|
|
hypertension, essential
|
[NCBI]
|
7.29826e-06
|
|
|
SLE
|
[NCBI]
|
7.25587e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
7.14552e-06
|
|
|
AIRE
|
[NCBI]
|
7.01435e-06
|
|
|
HDAC1
|
[NCBI]
|
6.88607e-06
|
|
|
IL4
|
[NCBI]
|
6.84417e-06
|
|
|
PRKCM
|
[NCBI]
|
6.60128e-06
|
|
|
ATM
|
[NCBI]
|
6.48502e-06
|
|
|
VEGF
|
[NCBI]
|
6.41106e-06
|
|
|
NPM1
|
[NCBI]
|
6.4093e-06
|
|
|
ESD
|
[NCBI]
|
6.19031e-06
|
|
|
HPRT1
|
[NCBI]
|
6.19031e-06
|
|
|
BLM
|
[NCBI]
|
6.16025e-06
|
|
|
porphyria variegata
|
[NCBI]
|
6.03055e-06
|
|
|
WRN
|
[NCBI]
|
5.77873e-06
|
|
|
MG
|
[NCBI]
|
5.73875e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
5.19066e-06
|
|
|
MEN2A
|
[NCBI]
|
4.97085e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
4.86405e-06
|
|
|
ACADM
|
[NCBI]
|
4.72924e-06
|
|
|
ALD
|
[NCBI]
|
4.45964e-06
|
|
|
DHFR
|
[NCBI]
|
3.80461e-06
|
|
|
DCK
|
[NCBI]
|
3.78507e-06
|
|
|
SCZD
|
[NCBI]
|
3.56121e-06
|
|
|
TG
|
[NCBI]
|
3.46466e-06
|
|
|
RB1
|
[NCBI]
|
3.37529e-06
|
|
|
TLR2
|
[NCBI]
|
3.07203e-06
|
|
|
TP53
|
[NCBI]
|
2.9317e-06
|
|
|
DBA
|
[NCBI]
|
2.31119e-06
|
|
|
MS
|
[NCBI]
|
2.31119e-06
|
|
|
LDLR
|
[NCBI]
|
2.11725e-06
|
|
|
STAT3
|
[NCBI]
|
1.86584e-06
|
|
|
CEACAM5
|
[NCBI]
|
1.57325e-06
|
|
|
BDNF
|
[NCBI]
|
1.27274e-06
|
|
|
MAG
|
[NCBI]
|
1.08503e-06
|
|
|
MPO
|
[NCBI]
|
1.06127e-06
|
|
|
AS
|
[NCBI]
|
9.82077e-07
|
|
|
PCNA
|
[NCBI]
|
8.56274e-07
|
|
|
HP
|
[NCBI]
|
8.14834e-07
|
|
|
SOD2
|
[NCBI]
|
4.77805e-07
|
|
|
ACP5
|
[NCBI]
|
4.13156e-07
|
|
|
G6PD
|
[NCBI]
|
4.06213e-07
|
|
|
VDR
|
[NCBI]
|
3.81903e-07
|
|
|
DGS
|
[NCBI]
|
2.41743e-07
|
|
|
FRAP1
|
[NCBI]
|
2.05628e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
1.64579e-07
|
|
|
PTK2
|
[NCBI]
|
1.56571e-07
|
|
|
HGF
|
[NCBI]
|
1.35275e-07
|
|
|
temporal arteritis
|
[NCBI]
|
6.56878e-08
|
|
|
TYMS
|
[NCBI]
|
3.79064e-08
|
|
|
TF
|
[NCBI]
|
1.34342e-08
|
|
|
AHR
|
[NCBI]
|
7.55334e-09
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.75326e-11
|
|